The impact of comorbidity on cancer and its treatment

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Ca

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3322/caac.21342PMID 26891458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival

  2016cited by this paper
• Living well with chronic illness: a call for public health action.

  2015cited by this paper
• The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people

  2015cited by this paper
• Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review.

  2015cited by this paper
• Importance of comborbidity in head and neck cancer

  2015cited by this paper
• The impact of patient comorbidity on cancer stage at diagnosis

  2015cited by this paper
• Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

  2015cited by this paper
• Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status.

  2014cited by this paper
• Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

  2014influential reference
• International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.

  2014cited by this paper
• Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer.

  2014cited by this paper
• An update on a systematic review of the use of geriatric assessment for older adults in oncology.

  2014cited by this paper
• Prostate Cancer Treatment and Survival: Evidence for Men With Prevalent Comorbid Conditions

  2014influential reference
• Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis

  2014cited by this paper
• Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.

  2014cited by this paper
• Development of a Pharmacy-based Comorbidity Index for Patients With Cancer

  2014cited by this paper
• A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes

  2014cited by this paper
• Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients

  2013cited by this paper
• The effect of multiple chronic conditions on self-rated health, disability and quality of life among the older populations of Northern Ireland and the Republic of Ireland: a comparison of two nationally representative cross-sectional surveys

  2013cited by this paper
• Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005

  2013cited by this paper
• Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

  2013cited by this paper
• Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.

  2013cited by this paper
• Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

  2013cited by this paper
• Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer

  2013cited by this paper
• Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis.

  2013cited by this paper
• The impact of comorbidity on cancer survival: a review

  2013cited by this paper
• Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study.

  2013cited by this paper
• Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database

  2013cited by this paper
• Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment.

  2013cited by this paper
• CDC Health Disparities and Inequalities Report - United States, 2013. Foreword.

  2013cited by this paper
• Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls.

  2013cited by this paper
• Influence of Comorbidity and Age on 1-, 2-, and 3-Month Postoperative Mortality Rates in Gastrointestinal Cancer Patients

  2013cited by this paper
• The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study

  2013cited by this paper
• Quality of life and comorbidity in localized malignant melanoma: results of a German population‐based cohort study

  2013cited by this paper
• Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer

  2013cited by this paper
• Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer

  2012cited by this paper
• Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites

  2012cited by this paper
• Diabetes and cancer II: role of diabetes medications and influence of shared risk factors

  2012cited by this paper
• Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review

  2012cited by this paper
• Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.

  2012cited by this paper
• Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo.

  2012cited by this paper
• Bone health in adult cancer survivorship.

  2012cited by this paper
• Age and comorbidity considerations related to radiotherapy and chemotherapy administration.

  2012cited by this paper
• Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality

  2012cited by this paper
• The Cancer Survival Query System: Making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients

  2012cited by this paper
• Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review

  2012cited by this paper
• A scoping review and thematic classification of patient complexity: offering a unifying framework

  2012cited by this paper
• The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study

  2012cited by this paper
• Review of methods used to measure comorbidity in cancer populations: no gold standard exists.

  2012cited by this paper
• Stage at Diagnosis and Comorbidity Influence Breast Cancer Survival in First Nations Women in Ontario, Canada

  2011cited by this paper
• Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review.

  2011influential reference
• A new comorbidity index: the health-related quality of life comorbidity index.

  2011cited by this paper
• Osteoporosis related to disease or therapy in patients with cancer.

  2011cited by this paper
• Self‐management: Enabling and empowering patients living with cancer as a chronic illness

  2011cited by this paper
• Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

  2011cited by this paper
• The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan.

  2011cited by this paper
• Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.

  2011cited by this paper
• Chemotherapy for older patients with colorectal cancer.

  2011cited by this paper
• Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study.

  2011cited by this paper
• Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study

  2011cited by this paper
• Potential drug interactions in elderly cancer patients.

  2011cited by this paper
• Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

  2011cited by this paper
• Adverse drug reactions and drug interactions as causes of hospital admission in oncology.

  2011cited by this paper
• Pulmonary tuberculosis increases the risk of lung cancer

  2011cited by this paper
• No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.

  2011cited by this paper
• The impact of comorbidity on treatment-related side effects in older patients with laryngeal cancer.

  2011cited by this paper
• THE NEW ZEALAND MEDICAL JOURNAL

  2011cited by this paper
• HIV and cancer in Germany.

  2011cited by this paper
• Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review

  2011cited by this paper
• Diabetes and Cancer

  2010influential reference
• How well does routine hospitalisation data capture information on comorbidity in New Zealand?

  2010cited by this paper
• CANCER LINKED TO ALZHEIMER DISEASE BUT NOT VASCULAR DEMENTIA

  2010cited by this paper
• What are the current barriers to effective cancer care coordination? A qualitative study

  2010cited by this paper
• Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy.

  2010cited by this paper
• A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status

  2010cited by this paper
• Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

  2010cited by this paper
• Cancer linked to Alzheimer disease but not vascular dementia

  2010cited by this paper
• The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer.

  2010cited by this paper
• The influence of medical comorbidities on the presentation and outcome of stage I-III non-small cell lung cancer.

  2010cited by this paper
• Chronic disease in men with newly diagnosed cancer: a nested case-control study.

  2010cited by this paper
• Linking diabetes and cancer: a consensus on complexity.

  2010cited by this paper
• Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

  2010cited by this paper
• Measuring cancer survival in populations: relative survival vs cancer-specific survival.

  2010cited by this paper
• HEALTH and HUMAN SERVICES

  2010influential reference
• Do racial or socioeconomic disparities exist in lung cancer treatment?

  2010cited by this paper
• Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors

  2010cited by this paper
• From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer

  2010cited by this paper
• Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy

  2010cited by this paper
• Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients

  2009cited by this paper
• Racial Differences in the Impact of Comorbidities on Survival Among Elderly Men With Prostate Cancer

  2009cited by this paper
• Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors

  2009cited by this paper
• Adverse drug reactions and drug interactions as causes of hospital admission in oncology.

  2009cited by this paper
• Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.

  2009cited by this paper
• Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer.

  2009cited by this paper
• The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study

  2009cited by this paper
• Impact of Age and Comorbidity on Colorectal Cancer Screening Among Older Veterans

  2009cited by this paper
• The Impact of Comorbidity on Survival of Danish Colorectal Cancer Patients from 1995 to 2006 - A Population-Based Cohort Study

  2009cited by this paper
• Effects of comorbidity on screening and early diagnosis of cancer in elderly people.

  2009cited by this paper
• Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.

  2009cited by this paper
• Drug interactions in oncology: how common are they?

  2009cited by this paper

• Comorbidity Level and Risk of 90-day and 18-month Complications Among Patients Undergoing Radical Prostatectomy for Prostate Cancer in the Military Health System

  2026cites this paper
• Real-world evaluation of health-related quality of life in hematology patients treated with rituximab: results of a multicentric cross-sectional cohort study

  2026cites this paper
• Second Primary Malignancies in Patients with Colorectal Cancer: The Frequency, Types, and Timeline

  2026influential citation
• Racial/Ethnic Disparities in Non-Small Cell Lung Cancer Mortality in the U.S., 2000-2020: A Population-Based Study.

  2026cites this paper
• Spatial distribution of timely treatment for cervical cancer: Socioeconomic inequalities and disparities in healthcare service availability in Brazil.

  2026cites this paper
• The impact of morbidity burden on cancer diagnosis; a retrospective cohort study in England.

  2026cites this paper
• Presentation, management, and outcomes of malignant vascular sarcomas: a National Cancer Database comparison of pediatrics and adults.

  2026cites this paper
• Determining Pdl1 Receptors Expression in Cervical Squamous Carcinoma with Various Clinico-Etio-Pathological Correlation

  2026cites this paper
• Cancer Comorbidities: Clinical Impacts, Mechanistic Insights, and Management Strategies

  2026cites this paper
• Diabetes mellitus is associated with earlier detection of posterior uveal melanoma.

  2026cites this paper
• Factors Associated With the Receipt of Female Breast Cancer Treatment Among People Living With Intellectual or Developmental Disabilities: A Population-Based Retrospective Cohort Study.

  2026cites this paper
• Hyperparameter Trajectory Inference with Conditional Lagrangian Optimal Transport

  2026cites this paper
• Exploring the role of resilience and quality of life in preoperative fear of cancer recurrence among patients with oral and maxillofacial cancer: A cross-sectional study

  2026cites this paper
• Healthcare costs and resource use in advanced breast cancer at the end of life: a register study

  2026cites this paper
• Knowledge, perceptions and attitudes toward diabetes care in oncology: a pilot survey across specialties (DiaLog Study)

  2026cites this paper
• Facilitators and barriers to help-seeking behavior for symptoms in patients with lung cancer in China—a qualitative study

  2026cites this paper
• A comprehensive nationwide registry study of noncommunicable disease comorbidities and death in cancer patients in Norway-the NCDNOR project.

  2026cites this paper
• Early Mortality Following Systemic Anticancer Therapy in Lung Cancer: A Bayesian Spatiotemporal Multilevel Analysis

  2026cites this paper
• Disparities in breast cancer detection modalities and outcomes among geriatric female cancer patients.

  2025cites this paper
• Evaluating 10 years of premature mortality costs associated with liver cancer: a retrospective economic analysis of productivity loss in Spain

  2025cites this paper
• Quantitative risk of underlying disease conditions for progression from monoclonal gammopathy to multiple myeloma: a nationwide cohort study

  2025cites this paper
• Comprehensive geriatric assessment and early treatment failure in nonagenarian patients with cancer, a retrospective monocentric study.

  2025cites this paper
• Association Between Comorbidity Clusters and Mortality in Patients With Cancer: Predictive Modeling Using Machine Learning Approaches of Data From the United States and Hong Kong

  2025cites this paper
• Socioeconomic Status and Breast Cancer Treatment in the United States: Results From a Systematic Literature Review

  2025cites this paper
• The impact of individuals' preventive behaviours on health and healthcare utilisation.

  2025cites this paper
• Trend and burden of adult cancer-related hospitalizations in the United States

  2025cites this paper
• Development and validation of crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/ quality of life scales and their corresponding PROMIS scales.

  2025cites this paper
• Group-based trajectory modeling for supportive care needs in Chinese cancer survivors: A systematic review

  2025cites this paper
• Comorbidity burden and risk of second primary non-breast cancer in breast cancer survivors.

  2025cites this paper
• Integrating Clinical and Transcriptomic Profiles Associated with Vitamin D to Enhance Disease-Free Survival in Cervical Cancer Recurrence Using the CatBoost Algorithm

  2025cites this paper
• Don't kill the patient before he dies.

  2025cites this paper
• Glucose tolerance and mortality across 24 cancer types and stages: A K‐CURE Nationwide registry study

  2025cites this paper
• Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement (Project CASCADE): a study protocol for a pragmatic, stepped-wedge, cluster-randomized trial in Texas primary care community health centers

  2025cites this paper
• Global burden, health inequalities and improvement gap of head and neck cancers in middle-aged and older adults from 1990 to 2021

  2025cites this paper
• Associations between cardiometabolic comorbidities and mortality in adults with cancer: multinational cohort study

  2025influential citation
• Impact of preoperative comorbidities on postoperative complication rates and survival outcome in patients with head and neck cancer undergoing surgical treatment

  2025cites this paper
• Clarifying the survival impact of immunotherapy in HR+/HER2- metastatic breast cancer: methodological caveats from a real-world perspective--letter to the editor.

  2025cites this paper
• Age Is Just a Number? A Retrospective Review of Cause of Death in Patients 85 Years and Over Receiving Lung Stereotactic Ablative Radiotherapy

  2025cites this paper
• Co‐Design of the Structured Personalised Assessment for Reviews After Cancer (SPARC) Intervention

  2025cites this paper
• Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study

  2025cites this paper
• Revolutionizing oncology care: pioneering AI models to foresee pneumonia-related mortality

  2025cites this paper
• Catastrophic health expenditures and food insecurity among older cancer survivors in the United States

  2025cites this paper
• Impact of comorbidities on survival in melanoma patients

  2025cites this paper
• Comorbidity and Risk of Complications and Readmissions Following Surgery for Patients With Renal Cell Carcinoma in the Military Health System.

  2025cites this paper
• Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer

  2025cites this paper
• Comorbid Non-Communicable Diseases in Cancer Patients: Burden, Patterns, and Trends

  2025cites this paper
• Teste Imunoquímico Fecal como Ferramenta de Rastreamento do Câncer Colorretal em Beiradeiros do Baixo São Francisco

  2025cites this paper
• Influence of healthy lifestyle on the incidence and survival of cancer and its comorbidities: evidence from a longitudinal cohort study

  2025cites this paper
• Social determinants of health in cancer survivors and the risk of cardiovascular events.

  2025cites this paper
• Multi-Target Therapeutics of Geraniin from Geranium wilfordii Maxim. and Related Species: Mechanisms and Applications.

  2025cites this paper
• Incidence, causes, and predictors of unplanned reoperation after craniotomy for brain metastases and its impact on patient outcomes

  2025cites this paper
• Mismatch between evidence and related clinical recommendations about the treatment of advanced esophageal cancer patients with anticancer drugs: A critical historical review.

  2025cites this paper
• The role of glycemic control and symptoms and symptom clusters in breast cancer survivors with type 2 diabetes

  2025cites this paper
• Cannabis Use Disorder and Mortality Among Patients with Colon Cancer.

  2025cites this paper
• The Global Burden of Esophageal Cancer in Older Adults: Spatiotemporal Patterns and Disparities, 1990-2021.

  2025cites this paper
• Enhancing Cancer Patient Navigation: Lessons from an Evaluation of Navigation Services in Alberta, Canada

  2025cites this paper
• Community-level Social Vulnerability and Cervical Cancer Mortality Among Young and Old Adults in the State of Alabama

  2025influential citation
• National variation in the treatment of lung cancer in a universal healthcare context

  2025cites this paper
• Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial

  2025cites this paper
• The prognostic role of Geriatric 8 in patients with cancer: a meta-analysis and systematic review

  2025cites this paper
• Predictive value of three comorbidity indices for survival endpoints in oral squamous cell carcinoma.

  2025cites this paper
• Prognostic impact of persistent postoperative neutrophil-to-lymphocyte ratio elevation 1 year after colorectal cancer surgery

  2025cites this paper
• New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

  2025cites this paper
• Novel Risk Calculator Predicting Long-Term Survival in Pediatric Versus Adult Patients Diagnosed with Spinal Low-Grade Glioma: A Nationwide Analysis.

  2025cites this paper
• Patient characteristics, serious disease diagnoses, and incidental findings in individuals with non-specific symptoms referred to the Suspected CANcer (SCAN) Pathway: a prospective cohort study in England

  2025cites this paper
• The cardio-oncology multidisciplinary team: beyond the basics

  2025cites this paper
• Type of pre-existing chronic conditions and their associations with Merkel cell carcinoma (MCC) treatment: Prediction and interpretation using machine learning methods

  2025influential citation
• Healthcare Costs by Comorbidity Patterns in Lung Cancer Patients

  2025cites this paper
• Interprofessional, risk-adapted medication management in older patients with cancer (IrMa).

  2025cites this paper
• Psychosocial and Demographic Factors Associated with Physical Multimorbidity in Severe Mental Illness: A Systematic Review.

  2025cites this paper
• Sex differences in the impact of multimorbidity on long-term mortality for patients with colorectal cancer: a population registry-based cohort study

  2025influential citation
• Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies.

  2025cites this paper
• Trends and Disparities in the Receipt of Treatment for Colon Cancer in Older Adults in Alberta, Canada.

  2025cites this paper
• Comorbidity prevalence and incidence in cancer survivors: a longitudinal All of Us study

  2025cites this paper
• Comorbid conditions and survival among Black women with ovarian cancer

  2025influential citation
• Geographic variation in delay to surgical treatment among non-small cell lung cancer patients.

  2025cites this paper
• Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine

  2025cites this paper
• Medication Management of Patients With Cancer Undergoing Surgery From Preadmission to Discharge: A Mixed‐Methods Systematic Review

  2025cites this paper
• Interaction of Hypertension and Diabetes Mellitus on Post-Cardiac Arrest Treatments and Outcomes in Cancer Patients Following Out-of-Hospital Cardiac Arrest

  2025cites this paper
• Navigating life after gastric cancer surgery: a qualitative exploration of the dyadic patient-caregiver perspective on quality of life outcomes

  2025cites this paper
• Mortality risk stratification based on comorbidity status among cervical cancer patients in Lagos, Nigeria

  2025influential citation
• The Prevalence of Multimorbidity Among Genitourinary Cancer Patients in Chile: A Retrospective Population-Based Study

  2025influential citation
• Age and Sex Differences in the Prevalence of Specific Comorbidities among Patients with Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma at Diagnosis

  2025cites this paper
• Are there inequalities in ovarian cancer diagnosis and treatment in England? A population-based study.

  2025cites this paper
• A machine learning tool for identifying metastatic colorectal cancer in primary care

  2025cites this paper
• Ethnic and Socio-Economic Variations in Comorbidity and Mortality in Cancer Survivors: A UK Population-Based Observational Study

  2025cites this paper
• Impact of Multimorbidity on Symptom Burden and Symptom Clusters in Patients Receiving Chemotherapy

  2025cites this paper
• Molecular Mechanisms of Genistein in Breast Cancer: From Oxidative Stress to Oncogenic Pathway Inhibition

  2025cites this paper
• Cancer stage at diagnosis by duration of pre-existing chronic analgesic use and anxiety or depression

  2025cites this paper
• Improving Care in Geriatric Oncology: A Call for Comprehensive and Personalized Approaches.

  2025cites this paper
• The Magnitude of Delay in Non-metastatic Breast Cancer Treatment in a Tertiary Hospital: an Analysis from 2012 to 2018

  2025cites this paper
• Attributing non-specific symptoms to cancer in general practice: A scoping review

  2025cites this paper
• Social determinants of health, health behaviors, and general health among colorectal cancer survivors: A cross-sectional study

  2025cites this paper
• Socioeconomic and Lifestyle Determinants of Breast Cancer Risk and Survival Outcomes in Urban versus Rural Settings in Thamar, Yemen.

  2025cites this paper
• Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

  2025influential citation
• Prevalence and impact of frailty in patients undergoing colorectal cancer surgery: A systematic review and meta‐analysis based on modified frailty index

  2024cites this paper
• Social Support Buffers the Effect of Social Deprivation on Comorbidity Burden in Adults with Cancer.

  2024cites this paper
• Computationally derived transition points across phases of clinical care

  2024cites this paper
• The prowess of metabolomics in cancer research: current trends, challenges and future perspectives

  2024cites this paper
• Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study

  2024cites this paper